Evidence for Molecular Mimicry between SARS‐CoV‐2 and Human Antigens: Implications for Autoimmunity in COVID‐19.
- Published in:
- Autoimmune Diseases (2090-0422), 2024, v. 2024, p. 1, doi. 10.1155/2024/8359683
- By:
- Publication type:
- Article
Works matching IS 20900422 AND DT 2024 AND VI 2024
Results: 5
1
2
Clinical Characteristics of Systemic Lupus Erythematosus in Caucasians and Latin American Hispanics: Data from a Single Tertiary Center.
- Published in:
- Autoimmune Diseases (2090-0422), 2024, v. 2024, p. 1, doi. 10.1155/2024/5593302
- By:
- Publication type:
- Article
3
Plasma/Serum Oxidant Parameters in Systemic Lupus Erythematosus Patients: A Systematic Review and Meta‐Analysis.
- Published in:
- Autoimmune Diseases (2090-0422), 2024, v. 2024, p. 1, doi. 10.1155/2024/9948612
- By:
- Publication type:
- Article
4
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center.
- Published in:
- Autoimmune Diseases (2090-0422), 2024, v. 2024, p. 1, doi. 10.1155/2024/6627035
- By:
- Publication type:
- Article
5
A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases.
- Published in:
- Autoimmune Diseases (2090-0422), 2024, v. 2024, p. 1, doi. 10.1155/2024/3968767
- By:
- Publication type:
- Article